Search - tctmd.com

Displaying 161 - 180 of 289

Sort: Relevancy | Date

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

Managing Multi-Valvular Disease and Considerations for Surgical Eligibility

Presenter: Joshua Goldberg

June 07, 2024

Presentation NY Valves 2024

Assessing Functional Status and Predicting Clinical Improvement

Presenter: Suzanne V. Arnold

June 07, 2024

Presentation NY Valves 2024

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Clinical Management of Symptomatic Patients with Severe Tricuspid Regurgitation

Presenter: Sean P. Pinney

June 07, 2024

Presentation NY Valves 2024

T-TEER - TRILUMINATE

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Presenter: Raj Makkar

June 07, 2024

Presentation NY Valves 2024

Clinical Implications of Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair: The TRI-SPA Registry

Presenter: Julio Cesar Echarte Morales

June 06, 2024

Presentation NY Valves 2024

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Next Generation LAAO Devices: Mechanisms, Unmet Needs, and Clinical Status

Presenter: Horst Sievert

June 06, 2024

Presentation NY Valves 2024

Role of Exercise Testing in Assessment of AR

Presenter: Robert O. Bonow

June 06, 2024

Presentation NY Valves 2024

RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making

Presenter: Ramesh Daggubati

June 06, 2024

Presentation NY Valves 2024

Con: Echocardiography Is Outdated –CMR Is the New Standard!

Presenter: Joao L. Cavalcante

June 06, 2024

Presentation NY Valves 2024

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Presenter: Shephal K. Doshi

June 06, 2024

Presentation NY Valves 2024

Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR

Presenter: Aarti Patil

June 06, 2024

Presentation NY Valves 2024

TricValve: Technology and Clinical Update

Presenter: Rishi Puri

June 06, 2024

Presentation NY Valves 2024

Current Status of LAAO in the United States: Device Utilization, Indications, and Clinical Outcomes

Presenter: Matthew J. Price

June 06, 2024

Presentation NY Valves 2024

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Presenter: Scott M. Chadderdon

June 06, 2024

Advertisement

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Managing Multi-Valvular Disease and Considerations for Surgical Eligibility

Assessing Functional Status and Predicting Clinical Improvement

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

Clinical Management of Symptomatic Patients with Severe Tricuspid Regurgitation

T-TEER - TRILUMINATE

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Clinical Implications of Recurrent Tricuspid Regurgitation After Transcatheter Edge-to-Edge Repair: The TRI-SPA Registry

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Next Generation LAAO Devices: Mechanisms, Unmet Needs, and Clinical Status

Role of Exercise Testing in Assessment of AR

RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making

Con: Echocardiography Is Outdated –CMR Is the New Standard!

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Pro: Echocardiographic Assessment Is Still the "Gold Standard" for AR

TricValve: Technology and Clinical Update

Current Status of LAAO in the United States: Device Utilization, Indications, and Clinical Outcomes

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content